{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:22:12Z","timestamp":1786119732943,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09819-6","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:41:10Z","timestamp":1785998470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FUNDC1-mediated mitochondrial quality control protects against immune checkpoint inhibitor\u2013associated cardiac injury"],"prefix":"10.1007","volume":"74","author":[{"given":"Nengfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"9819_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113365","volume":"143","author":"M Arafat Hossain","year":"2024","unstructured":"Arafat Hossain M. A comprehensive review of immune checkpoint inhibitors for cancer treatment. Int Immunopharmacol. 2024;143:113365.","journal-title":"Int Immunopharmacol"},{"key":"9819_CR2","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1016\/S1470-2045(24)00075-5","volume":"25","author":"C Lynch","year":"2024","unstructured":"Lynch C, Pitroda SP, Weichselbaum RR. Radiotherapy, immunity, and immune checkpoint inhibitors. Lancet Oncol. 2024;25:e352\u201362.","journal-title":"Lancet Oncol"},{"key":"9819_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02176-8","volume":"23","author":"M Jin","year":"2024","unstructured":"Jin M, Fang J, Peng J, Wang X, Xing P, Jia K, et al. PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies. Mol Cancer. 2024;23:266.","journal-title":"Mol Cancer"},{"key":"9819_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-024-01581-2","volume":"17","author":"W Cheng","year":"2024","unstructured":"Cheng W, Kang K, Zhao A, Wu Y. Dual blockade immunotherapy targeting PD-1\/PD-L1 and CTLA-4 in lung cancer. J Hematol Oncol. 2024;17:54.","journal-title":"J Hematol Oncol"},{"key":"9819_CR5","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.7150\/thno.95971","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y, Li F, Xu L, Shi X, Xue H, Liu J, et al. Single cell analyses reveal the PD-1 blockade response-related immune features in hepatocellular carcinoma. Theranostics. 2024;14:3526\u201347.","journal-title":"Theranostics"},{"key":"9819_CR6","first-page":"eadf1329","volume-title":"Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients","author":"D Mathew","year":"2024","unstructured":"Mathew D, Marmarelis ME, Foley C, Bauml JM, Ye D, Ghinnagow R, et al. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Volume 384. New York, NY: Science; 2024. p. eadf1329."},{"key":"9819_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s41588-025-02077-6","volume":"57","author":"L Liang","year":"2025","unstructured":"Liang L, Kuang X, He Y, Zhu L, Lau P, Li X, et al. Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma. Nat Genet. 2025;57:680\u201393.","journal-title":"Nat Genet"},{"key":"9819_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ccell.2024.11.008","volume":"43","author":"Z Yang","year":"2025","unstructured":"Yang Z, Liu X, Zhu J, Chai Y, Cong B, Li B, et al. Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1. Cancer Cell. 2025;43:86\u2013e10210.","journal-title":"Cancer Cell"},{"key":"9819_CR9","doi-asserted-by":"publisher","first-page":"1340373","DOI":"10.3389\/fimmu.2024.1340373","volume":"15","author":"W Jo","year":"2024","unstructured":"Jo W, Won T, Daoud A, \u010cih\u00e1kov\u00e1 D. Immune checkpoint inhibitors associated cardiovascular immune-related adverse events. Front Immunol. 2024;15:1340373.","journal-title":"Front Immunol"},{"key":"9819_CR10","first-page":"e075859","volume":"385","author":"NL Palaskas","year":"2024","unstructured":"Palaskas NL, Ali HJ, Koutroumpakis E, Ganatra S, Deswal A. Cardiovascular toxicity of immune therapies for cancer. BMJ (Clinical Res ed). 2024;385:e075859.","journal-title":"BMJ (Clinical Res ed)"},{"key":"9819_CR11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1158\/2159-8290.CD-22-1180","volume":"13","author":"JE Salem","year":"2023","unstructured":"Salem JE, Bretagne M, Abbar B, Leonard-Louis S, Ederhy S, Redheuil A, et al. Abatacept\/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discov. 2023;13:1100\u201315.","journal-title":"Cancer Discov"},{"key":"9819_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41568-024-00715-5","volume":"24","author":"AZ Munir","year":"2024","unstructured":"Munir AZ, Gutierrez A, Qin J, Lichtman AH, Moslehi JJ. Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart. Nat Rev Cancer. 2024;24:540\u201353.","journal-title":"Nat Rev Cancer"},{"key":"9819_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2323052121","volume":"121","author":"H Kalinoski","year":"2024","unstructured":"Kalinoski H, Daoud A, Rusinkevich V, Jur\u010dov\u00e1 I, Talor MV, Welsh RA, et al. Injury-induced myosin-specific tissue-resident memory T cells drive immune checkpoint inhibitor myocarditis. Proc Natl Acad Sci U S A. 2024;121:e2323052121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9819_CR14","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","volume":"5","author":"A Picca","year":"2023","unstructured":"Picca A, Faitg J, Auwerx J, Ferrucci L, D\u2019Amico D. Mitophagy in human health, ageing and disease. Nat metabolism. 2023;5:2047\u201361.","journal-title":"Nat metabolism"},{"key":"9819_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12929-023-00975-7","volume":"30","author":"L Liu","year":"2023","unstructured":"Liu L, Li Y, Chen G, Chen Q. Crosstalk between mitochondrial biogenesis and mitophagy to maintain mitochondrial homeostasis. J Biomed Sci. 2023;30:86.","journal-title":"J Biomed Sci"},{"key":"9819_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ncb2422","volume":"14","author":"L Liu","year":"2012","unstructured":"Liu L, Feng D, Chen G, Chen M, Zheng Q, Song P, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 2012;14:177\u201385.","journal-title":"Nat Cell Biol"},{"key":"9819_CR17","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.7150\/thno.92771","volume":"14","author":"W He","year":"2024","unstructured":"He W, Sun Z, Tong G, Zeng L, He W, Chen X, et al. FUNDC1 alleviates doxorubicin-induced cardiotoxicity by restoring mitochondrial-endoplasmic reticulum contacts and blocked autophagic flux. Theranostics. 2024;14:3719\u201338.","journal-title":"Theranostics"},{"key":"9819_CR18","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1080\/15548627.2017.1300224","volume":"13","author":"W Zhang","year":"2017","unstructured":"Zhang W, Siraj S, Zhang R, Chen Q. Mitophagy receptor FUNDC1 regulates mitochondrial homeostasis and protects the heart from I\/R injury. Autophagy. 2017;13:1080\u20131.","journal-title":"Autophagy"},{"key":"9819_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119151","volume":"24","author":"X Bai","year":"2023","unstructured":"Bai X, Zhang Z, Li X, Yang Y, Ding S. FUNDC1: an emerging mitochondrial and MAMs protein for mitochondrial quality control in heart diseases. Int J Mol Sci. 2023;24:9151.","journal-title":"Int J Mol Sci"},{"key":"9819_CR20","doi-asserted-by":"publisher","first-page":"e090087","DOI":"10.1136\/bmjopen-2024-090087","volume":"15","author":"W Shan","year":"2025","unstructured":"Shan W, Zhu J, Shen J. Gender and age disparities in cardiac immune-related adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FAERS database. BMJ open. 2025;15:e090087.","journal-title":"BMJ open"},{"key":"9819_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/bph.15984","volume":"180","author":"TG Gergely","year":"2023","unstructured":"Gergely TG, Kucsera D, T\u00f3th VE, Kov\u00e1cs T, Sayour NV, Drobni ZD, et al. Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment. Br J Pharmacol. 2023;180:740\u201361.","journal-title":"Br J Pharmacol"},{"key":"9819_CR22","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","volume":"375","author":"DB Johnson","year":"2016","unstructured":"Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, et al. Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med. 2016;375:1749\u201355.","journal-title":"N Engl J Med"},{"key":"9819_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/jleuko\/qiad056","volume":"114","author":"J Gao","year":"2023","unstructured":"Gao J, Wang Y, Lu L, Ma M, Ling J, Sun L, et al. Peripheral immune mapping and multi-omics analysis in Pd-1 inhibitor-induced myocarditis. J Leukoc Biol. 2023;114:164\u201379.","journal-title":"J Leukoc Biol"},{"key":"9819_CR24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20251717","volume":"223","author":"KA Warrick","year":"2026","unstructured":"Warrick KA, Johansen AKZ, Jiao M, Linnemann ME, Saha I, Lin SJ, et al. Immune checkpoint inhibitor-induced myocarditis is dependent on CD8 T cell-derived TNF and TNFR2 signaling. J Exp Med. 2026;223:e20251717.","journal-title":"J Exp Med"},{"key":"9819_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/CIRCULATIONAHA.123.067504","volume":"151","author":"Y Yamada","year":"2025","unstructured":"Yamada Y, Sadahiro T, Nakano K, Honda S, Abe Y, Akiyama T, et al. Cardiac reprogramming and Gata4 overexpression reduce fibrosis and improve diastolic dysfunction in heart failure with preserved ejection fraction. Circulation. 2025;151:379\u201395.","journal-title":"Circulation"},{"key":"9819_CR26","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41586-025-08945-9","volume":"642","author":"S Cho","year":"2025","unstructured":"Cho S, Rhee S, Madl CM, Caudal A, Thomas D, Kim H, et al. Selective inhibition of stromal mechanosensing suppresses cardiac fibrosis. Nature. 2025;642:766\u201375.","journal-title":"Nature"},{"key":"9819_CR27","first-page":"841","volume":"38","author":"J Wu","year":"2025","unstructured":"Wu J, Mei T, Dong Y, Zhang F, Li X, Wang L. Mitophagy as a therapeutic target for myocardial fibrosis: Mechanistic insights and potential pharmacological interventions. Pak J Pharm Sci. 2025;38:841\u201352.","journal-title":"Pak J Pharm Sci"},{"key":"9819_CR28","doi-asserted-by":"publisher","first-page":"1453365","DOI":"10.3389\/fcell.2024.1453365","volume":"12","author":"K Li","year":"2024","unstructured":"Li K, Xia X, Tong Y. Multiple roles of mitochondrial autophagy receptor FUNDC1 in mitochondrial events and kidney disease. Front cell Dev biology. 2024;12:1453365.","journal-title":"Front cell Dev biology"},{"key":"9819_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jare.2023.02.012","volume":"55","author":"Y Bi","year":"2024","unstructured":"Bi Y, Liu S, Qin X, Abudureyimu M, Wang L, Zou R, et al. FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner. J Adv Res. 2024;55:45\u201360.","journal-title":"J Adv Res"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09819-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09819-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09819-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:03:14Z","timestamp":1786042994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09819-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9819"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09819-6","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed in strict accordance with the ARRIVE guidelines and were approved by the Animal Care and Use Committee of The Second People\u2019s Hospital of Huai\u2019an\/The Affiliated Huai\u2019an Hospital of Xuzhou Medical University (Approval No.: HEYLL2024110). The study adhered to the US National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85\u2009\u2212\u200923, revised 1996).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests\u00a0","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"78"}}